profit from every €100 of sales.
€0€100
Drägerwerk AG & Co. KGaA
€112.00+0.90% today
+63.0% since Dec 21, 25
1-year low €68.401-year high €124.60
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay €15.06 for every €1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Drägerwerk AG & Co. KGaA sold, what it kept, and what it did with the cash.
Sales went from €3.05 billion in 2022 to €3.48 billion in 2025, with €139 million of profit last year.
SalesProfit
Drägerwerk AG & Co. KGaA handed back 28% of the cash it generated last year.
€37M
Free cash flow 2025€158M
Bought back its own shares€6M
Paid as dividends€37M
Cash vs. debt€266M vs. €405M
Drägerwerk AG & Co. KGaA vs. similar companies
Drägerwerk AG & Co. KGaA grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| Drägerwerk AG & Co. KGaA | 15.1× · Fair price | ||
 Abbott Laboratories | 28.8× · Fair price | ||
 Medtronic | 27.4× · Fair price | ||
 Stryker | 36.3× · Expensive | ||
 Edwards Lifesciences | 57.4× · Expensive |
AI analysis
An AI analyst reads Drägerwerk AG & Co. KGaA's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 3,045 | 3,374 | 3,371 | 3,482 | |
| 1,238 | 1,460 | 1,512 | 1,574 | |
| -80 | 184 | 180 | 232 | |
| -80 | 172 | 202 | 243 | |
| -65 | 110 | 124 | 139 | |
| -3.47 | 5.86 | 6.61 | 7.42 | |
| 40.7% | 43.3% | 44.9% | 45.2% | |
| -2.6% | 5.5% | 5.3% | 6.7% | |
| -2.1% | 3.3% | 3.7% | 4.0% |
Balance sheet
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 3,107 | 3,095 | 3,093 | 3,163 |
| Cash | 302 | 260 | 223 | 266 |
| Total debt | 362 | 471 | 396 | 405 |
| Total liabilities | 1,787 | 1,685 | 1,557 | 1,534 |
| 1,318 | 1,407 | 1,535 | 1,626 | |
| 19 | 19 | 19 | 19 | |
| -3.3% | 6.4% | 7.3% | 8.4% | |
| -4.9% | 7.9% | 8.1% | 8.6% |
Cash flow
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -144 | 190 | 167 | 238 | |
| 87 | 68 | 64 | 81 | |
| -231 | 121 | 104 | 158 | |
| Dividends paid | 4 | 4 | 33 | 37 |
| 5 | 4 | 3 | 6 | |
| – | – | – | – |
Valuation
- 15.1×
- –
- –
- 1.0×
- 0.6×
- 13.3×
- 9.2×
- 7.5%
- 6.6%
- 1.8%
Profitability
- 45.2%
- 6.7%
- 4.0%
- –
- 8.4%
- 4.7%
- –
- –
- –
- –
Growth
- +4.6%
- –
- –
- –
- −0.0%
Financial health
- –
- 0.25
- –
- 8.7×
- 2.03
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 39%of 964
Bottom 37%of 898
Top 21%of 651
Bottom 28%of 911
Top 12%of 991
1.8%of the share price, paid each year
On $1,000 invested$18a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
26.9% of its profit
Room to growStretchedMore than it earns: 23.8%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
52No pass
Benjamin Graham
65Pass
Philip Fisher
45No pass
Peter Lynch
44No pass
Joel Greenblatt
45No pass
Charlie Munger
46No pass
Terry Smith
47No pass
Questions about Drägerwerk AG & Co. KGaA
Is Drägerwerk AG & Co. KGaA a good stock to buy?
A business with weak numbers at a fair price. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Drägerwerk AG & Co. KGaA AI analysis
What does Drägerwerk AG & Co. KGaA do?
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. It is in Medical Devices, based in Lübeck, Germany, with 16,033 employees.
Does Drägerwerk AG & Co. KGaA pay a dividend?
Yes. At today's price the dividend is 1.8% a year, about 27% of its yearly profit. In 2025 it paid out €37.5 million in dividends.
Is Drägerwerk AG & Co. KGaA stock halal?
Yes. Drägerwerk AG & Co. KGaA passes our halal screen: its business is permitted and its debt is 19% of its market value, under the 30% limit. How we check
Who are Drägerwerk AG & Co. KGaA's competitors?
The largest listed companies in the same industry are Abbott Laboratories, Medtronic, Stryker and Edwards Lifesciences. The peers table on this page compares their profit, growth and price with Drägerwerk AG & Co. KGaA's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.